Laboratory diagnostics

134

Common urine analysis

1.2.

registration of material ( primary and final), patient passport data and test results in registers and forms or in PC

registration

1,32

0

1,32

38

0,4

0,5

2.

general analysis

2.1.

urine analysis:

2.1.1.

definition of quantity, color, transparency, presence of sediment,relative density, pH

analysis

0,44

0,26

0,7

20

0,2

0,3

2.1.3.

protein sensing:

2.1.3.2.

with sulfosalicylic acid

analysis

0,44

0,01

0,45

13

0,1

0,2

2.1.9.

analysis of common urine analysis complex parameters with semi-automatic analyzers on basis of dry chemicals method анализаторов на

analysis

0,88

0,36

1,24

36

0,4

0,5

2.1.10.

microscopical analysis of sediment:

2.1.10.1.

normal

analysis

1,16

0,13

1,29

37

0,4

0,5

TOTAL

5,00

144

1,6

1,9

135

Zymitsky's urine analysis

1.2.

registration of material ( primary and final), patient passport data and test results in registers and forms or in PC

analysis

1,32

0

1,32

38

0,4

0,5

2.

general analysis

2.1.

urine analysis

2.1.12.

concentrating ability of kidneys definition after Zymitsky

analysis

2,92

0,02

2,94

85

0,9

1,1

TOTAL

4,26

123

1,4

1,6

136

Nicheporenko's urine test

1.2.

registration of material ( primary and final), patient passport data and test results in registers and forms or in PC

registration

1,32

0

1,32

38

0,4

0,5

2.

general analysis

2.1.

urine analysis

2.1.11.

calculation of formed elements quantity by Nicheporenko's method

analysis

4,24

0,16

4,40

127

1,4

1,7

TOTAL

5,72

165

1,8

2,2

137

Common blood test with differential leukocyte count

1.2.

registration of material ( primary and final), patient passport data and test results in registers and forms or in PC

registration

1,32

0,00

1,32

38

0,4

0,5

1.3.

finger blood drawing:

1.3.2.

for full range of hematologic study within common blood test concept, including differential leukocyte count

1,16

1,06

2,22

64

0,7

0,8

3.

hematologic study

3.7.

erythrocyte sedimentation test

analysis

0,60

0,00

0,60

17

0,2

0,2

3.9.

differential leukocyte count with blood corpuscle morphology description:

3.9.1.

for nonhematologic diseases

analysis

3,92

0,37

4,29

124

1,4

1,6

3.26.

tests with blood analyzers:

3.26.2.

automatic, without differential leukocyte count

analysis

3,12

2,14

5,26

152

1,7

2,0

TOTAL

13,69

395

4,4

5,2

138

Glucose determination in whole blood by express test

5.2.7.

glucose determination in whole blood by express test

analysis

2,50

1,33

3,83

111

1,2

1,5

139

Biochemical blood analyses

1.2.

registration of material ( primary and final), patient passport data and test results in registers and forms or in PC

registration

1,32

0

1,32

38

0,4

0,5

1.

separate operation:

1.1.3.

pipette with automatic doser

pipette

0,04

0,28

0,32

9,2

0,1

0,1

1.4.

vein blood sampling

1,46

1,42

2,88

83,2

0,9

1,1

1.5.

treatment of vein blod for getting plasma or serum

0,88

0,07

0,95

27,4

0,3

0,4

TOTAL

5,47

158,0

1,8

2,1

5.13.

tests with multichannel biochemical auto-analyzers:

5.13.1.2

automatic test result registration  CRUDE PROTEINE

analysis

0,56

0,28

0,84

24,3

0,3

0,3

5.13.1.2

автоматизированная регистрация результатов исследований  ALBUMIN

analysis

0,56

0,57

1,13

32,6

0,4

0,4

5.13.1.2

automatic test result registration UREA

analysis

0,56

0,34

0,9

26,0

0,3

0,3

5.13.1.2

automatic test result registration FRUCTOSAMINE

analysis

0,56

0,27

0,83

24,0

0,3

0,3

5.13.1.2

automatic test result registration CREATININE

analysis

0,56

0,30

0,86

24,8

0,3

0,3

5.13.1.2

automatic test result registration URIC ACID

analysis

0,56

0,34

0,9

26,0

0,3

0,3

5.13.1.2

automatic test result registration TOTAL BILIRUBIN

analysis

0,56

0,30

0,86

24,8

0,3

0,3

5.13.1.2

automatic test result registration DIRECT REACTING BILIRUBIN

analysis

0,56

0,30

0,86

24,8

0,3

0,3

5.13.1.2

автоматизированная регистрация результатов исследований GLYCATED HEMOGLOBIN

analysis

0,56

10,89

11,45

330,8

3,7

4,3

5.13.1.2

automatic test result registration GLUCOSE

analysis

0,56

0,28

0,84

24,3

0,3

0,3

5.13.1.2

automatic test result registration TOTAL CHOLESTEROL

analysis

0,56

0,32

0,88

25,4

0,3

0,3

5.13.1.2

automatic test result registration TRIGLYCERIDES

analysis

0,56

0,41

0,97

28,0

0,3

0,4

5.13.1.2

automatic test result registration CHOLESTEROL HDL

analysis

0,56

0,98

1,54

44,5

0,5

0,6

5.13.1.2

automatic test result registration CHOLESTEROL LDL

analysis

0,56

2,85

3,41

98,5

1,1

1,3

MINERAL METABOLISM MARKERS

5.13.1.2

automatic test result registration  CALCIUM

analysis

0,56

1,61

2,17

62,7

0,7

0,8

5.13.1.2

automatic test result registration PHOSPHOR

analysis

0,56

0,37

0,93

26,9

0,3

0,4

5.13.1.2

automatic test result registration MAGNESIUM

analysis

0,56

0,31

0,87

25,1

0,3

0,3

5.13.1.2

automatic test result registration FERRUM

analysis

0,56

0,37

0,93

26,9

0,3

0,4

5.13.1.2

Serum glutamic oxalacetic transaminase (АСТ)

analysis

0,56

0,33

0,89

25,7

0,3

0,3

5.13.1.2

Aminotransferase(АLТ)

analysis

0,56

0,32

0,88

25,4

0,3

0,3

5.13.1.2

automatic test result registration AMYLASE

analysis

0,56

0,70

1,26

36,4

0,4

0,5

5.13.1.2

automatic test result registration ALKALINE PHOSPHATASE

analysis

0,56

0,31

0,87

25,1

0,3

0,3

5.13.1.2

automatic test result registration  GAMMA-GLUTAMYLTRANSFERASE

analysis

0,56

0,42

0,98

28,3

0,3

0,4

5.13.1.2

automatic test result registration  LIPASE

analysis

0,56

2,94

3,50

101,1

1,1

1,3

5.13.1.2

automatic test result registration LACTATE DEHYDROGENASE

analysis

0,56

0,44

1,00

28,9

0,3

0,4

5.13.1.2

automatic test result registration С-REACTIVE PROTEIN

analysis

0,56

1,59

2,15

62,1

0,7

0,8

5.13.1.2

automatic test result registration Creatine Kinase-MB

analysis

0,56

1,66

2,22

64,1

0,7

0,8

5.13.1.2

automatic test result registration  FERRITIN

analysis

0,56

2,06

2,62

75,7

0,8

1,0

5.13.1.2

automatic test result registration  TRANSFERIN

analysis

0,56

0,53

1,09

31,5

0,4

0,4

140

PRESECRETION DETERMINATION

by enzyme immunodetection method

1.2.

registration of material ( primary and final), patient passport data and test results in registers and forms or in PC

registration

1,32

0

1,32

38,1

0,4

0,5

1.4.

vein blood sampling

sample

1,46

1,42

2,88

83,2

0,9

1,1

1.5.

treatment of vein blood to get plasma or serum

sample

0,88

0,07

0,95

27,4

0,3

0,4

1.1.2.

pipetting with automanual dosers (6 times)

sample

0,36

0,60

0,96

27,7

0,3

0,4

TOTAL

6,11

176,5

2,0

2,3

Определение гормонов щитовидной железы методом иммуноферментного анализа c полуавтоматическим расчетом

1.1. Thyroid panel

5.9.1.2.

Antibodies to thyroid peroxidase(АТ-ТPO)

analysis

2,82

3,59

6,41

185,2

2,1

2,4

5.9.1.2.

Antithyroglobulin antibodies (АТTG)

analysis

2,82

3,00

5,82

168,1

1,9

2,2

5.9.1.2.

Thyreoglobulin (TG)

analysis

2,82

3,44

6,26

180,8

2,0

2,4

5.9.1.2.

Thyrotrophic hormone (ТТГ, thyroliberin, Thyroid Stimulating Hormone, TSH)

analysis

2,82

3,08

5,9

170,4

1,9

2,2

5.9.1.2.

Free thyroxin  (Т4 free)

analysis

2,82

3,73

6,55

189,2

2,1

2,5

5.9.1.2.

Triiodothyronine  (Т3 )

analysis

2,82

1,80

4,62

133,5

1,5

1,8

1.2. Reproductive panel

Sex hormones determination by enzyme immunodetection analysis

5.9.1.2.

Follicle-stimulating hormone, FSH

analysis

2,82

3,21

6,03

174,2

1,9

2,3

5.9.1.2.

Luteinizing hormone , LH

analysis

2,82

3,31

6,13

177,1

2,0

2,3

5.9.1.2.

 Prolactin

analysis

2,82

3,25

6,07

175,4

2,0

2,3

5.9.1.2.

Testosterone

analysis

2,82

3,09

5,91

170,7

1,9

2,2

5.9.1.2.

Progesterone

analysis

2,82

2,43

5,25

151,7

1,7

2,0

5.9.1.2.

Estradiol

analysis

2,82

11,41

14,23

411,1

4,6

5,4

1.3. Adrenocortical panel

5.9.1.2.

Hydrocortisone

analysis

2,82

3,08

5,9

170,4

1,9

2,2

4. Cancer panel

analysis

5.9.1.2.

PSA total (prostate specific antigen total, Prostate-specific antigen total, PSA total)

analysis

2,82

3,09

5,91

170,7

1,9

2,2

5.9.1.2.

CA-15-3 antigen

analysis

2,82

9,59

12,41

358,5

4,0

4,7

5.9.1.2.

CA-125 antigen

analysis

2,82

3,87

6,69

193,3

2,2

2,5

5.9.1.2.

Gonadotropin

analysis

2,82

3,21

6,03

174,2

1,9

2,3

5.9.1.2.

Insulin

analysis

2,82

23,24

26,06

752,9

8,4

9,9

141

Coagulogram:

1.2.

registration of material ( primary and final), patient passport data and test results in registers and forms or in PC

registration

1,32

0

1,32

38,1

0,4

0,5

1.4.

vein blood sampling

sample

1,46

1,20

2,66

76,8

0,9

1,0

1.5.

treatment of vein blood to get plasma or serum

sample

0,88

0,07

0,95

27,4

0,3

0,4

1.1.2.

pipetting with automanual dosers

pipette

0,06

0,10

0,16

4,6

0,1

0,1

TOTAL

5,09

147,0

1,6

1,9

Defining of prothrombin(thromboplastin) time, PTT with computation of international normalized time

6.2.1.

Defining of prothrombin(thromboplastin) time with  thromboplastin-calcium mixture

analysis

1,00

3,26

4,26

123,1

1,4

1,6

6.3.

correction test on prothrombin time with thromboplastin-calcium mix

analysis

6,66

2,27

8,93

258,0

2,9

3,4

TOTAL

13,19

381,0

4,3

5,0

142

Determination of activated recalcification time plasma with kaolin suspension  

6.1.

Determination of activated recalcification time of plasma with kaolin suspension  

analysis

6,66

1,94

8,60

248,4

2,8

3,3

Determination of fibrinogen in blood plasma   

6.6.3.

Determination of fibrinogen in blood plasma, automanual computation  

исслед.

2,09

2,07

4,16

120,2

1,3

1,6

detection of Trichomonas and gonococci in preparations of urinary tract discharge

2.10.1.

detection of Trichomonas and gonococci in methylene blue-stained preparations of urinary tract discharge

analysis

4,86

0,02

4,88

141,0

1,6

1,9